文献速递头颈部肿瘤放疗放疗物理与技术

全身铜螯合减少受照小鼠唾液腺胶原沉积并保留分泌功能

Systemic Copper Chelation Reduces Collagen Deposition and Preserves Secretory Function in Irradiated Mouse Salivary Glands.
PubMed 文献 · Adv Radiat Oncol · 2026-07-22

头颈癌放疗常致唾液腺纤维化和分泌功能丧失。本研究在小鼠颈部单次15 Gy照射前7天至后7天经饮水给予四硫钼酸盐(TTM,0.1 mg/mL),发现全身TTM可到达颌下腺、可逆降低铜生物利用度,减轻放疗所致胶原沉积和上皮损伤,并在照射后30天时使刺激唾液流率显著高于对照饮水组。

要点

  • 全身TTM经饮水给药可到达颌下腺并可逆降低铜生物利用度。
  • TTM减轻放疗所致胶原沉积和上皮损伤,并促进ZO-1表达恢复。
  • 照射后30天TTM组刺激唾液流率显著高于对照饮水组。

核心结论

  • 全身TTM给药降低铜生物利用度,减轻放疗所致胶原沉积和上皮损伤,并保留唾液腺分泌功能。
  • 这些发现支持全身铜螯合作为局部TTM给药的微创替代方案,用于限制放疗所致唾液腺损伤。

研究设计与样本

  • 小鼠在颈部单次15 Gy放疗前7天至放疗后7天经饮水给予TTM(0.1 mg/mL)。
  • 通过测量钼和铜水平及血清铜蓝蛋白活性评估全身TTM暴露和铜生物利用度。
  • 通过胶原沉积、组织病理学、上皮完整性和刺激唾液分泌评估放疗所致唾液腺损伤。

主要发现

  • 全身TTM到达颌下腺并可逆降低铜生物利用度,表现为钼水平升高、铜/钼比值降低和血清铜蓝蛋白活性抑制。
  • TTM减轻放疗所致胶原沉积和上皮损伤,并促进ZO-1表达恢复。
  • 放疗后30天,TTM处理受照小鼠的刺激唾液流率显著高于接受常规饮水的受照小鼠。

临床怎么用

  • 全身铜螯合可作为局部TTM给药的微创替代途径,用于减轻头颈放疗所致唾液腺损伤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation therapy (RT) for head and neck cancer commonly causes fibrosis of the salivary gland (SG) and loss of secretory function. We previously demonstrated that transdermal injection of the copper chelator tetrathiomolybdate into irradiated submandibular glands reduced the early deposition of fibrillar collagen and preserved their integrity and function. Although these studies identified copper metabolism as a novel therapeutic target to control RT-induced damage to the SG, local delivery of copper chelators in human SG presents clinical hurdles including specialized personnel and equipment needed for administration together with the discomfort felt by patients upon receiving this treatment. To overcome these issues, the current study investigated whether systemic administration of tetrathiomolybdate (TTM) via drinking water could similarly reduce collagen deposition and preserve secretory function. METHODS AND MATERIALS: Mice received TTM in drinking water (0.1 mg/mL) beginning 7 days before and continuing through 7 days after a single 15-Gy dose of RT to the neck. Systemic TTM exposure and copper bioavailability were assessed by measuring molybdenum and copper levels and serum ceruloplasmin activity. RT-induced SG injury was evaluated by collagen deposition, histopathology, epithelial integrity, and stimulated saliva secretion. RESULTS: Systemically administered TTM reached the submandibular gland and reversibly reduced copper bioavailability, as demonstrated by increased molybdenum levels, reduced copper-to-molybdenum ratios, and suppression of serum ceruloplasmin activity. Moreover, TTM treatment attenuated RT-induced collagen deposition and epithelial damage and promoted recovery of ZO-1 expression. Finally, at 30 days after RT, stimulated saliva flow was significantly higher in TTM-treated irradiated mice than in irradiated mice receiving regular water. CONCLUSION: Systemic TTM administration reduces copper bioavailability, attenuates RT-induced collagen deposition and epithelial injury, and preserves SG secretory function. These findings support systemic copper chelation as a less invasive alternative to local TTM delivery for limiting RT-induced SG damage.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Nam K, Maslow FM, Santos HTD, et al. Systemic Copper Chelation Reduces Collagen Deposition and Preserves Secretory Function in Irradiated Mouse Salivary Glands. Adv Radiat Oncol. 2026. PMID: 42668541. doi:10.1016/j.adro.2026.102149

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。